Pharmacy Research - Drug Stores, Prescriptions, Health Care

Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.


Pharmacy Research Today

Home

View Latest Issue

Information About Pharmacy

Books on Pharmacy

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2008), Issue 5 (May)

  1. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    J Urban Health, 85(3): 309-22. [Abstract] [Full-text]
  2. Provider characteristics among staff providing care to sexually transmitted infection self-medicating patients in retail pharmacies in Kibera slum, Nairobi, Kenya.
    Sex Transm Dis, 35(5): 480-3. [Abstract] [Full-text]
  3. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.
    Pharmacotherapy, 28(5): 562-9. [Abstract] [Full-text]
  4. Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats.
    Naunyn Schmiedebergs Arch Pharmacol. [Abstract] [Full-text]
  5. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
    Arch Pharm Res, 31(4): 547-54. [Abstract] [Full-text]
  6. Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes.
    Arch Pharm Res, 31(4): 539-46. [Abstract] [Full-text]
  7. Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.
    Arch Pharm Res, 31(4): 530-8. [Abstract] [Full-text]
  8. Enantioselective determination of chlorpheniramine in various formulations by HPLC using carboxymethyl-beta-cyclodextrin as a chiral additive.
    Arch Pharm Res, 31(4): 523-9. [Abstract] [Full-text]
  9. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Arch Pharm Res, 31(4): 518-22. [Abstract] [Full-text]
  10. Anti-hyperalgesic and anti-inflammatory effects of Ketorolac Tromethamine gel using pulsed ultrasound in inflamed rats.
    Arch Pharm Res, 31(4): 511-7. [Abstract] [Full-text]
  11. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Arch Pharm Res, 31(4): 503-10. [Abstract] [Full-text]
  12. Combinatorial anti-Trichophyton effects of Ligusticum chuanxiong essential oil components with antibiotics.
    Arch Pharm Res, 31(4): 497-502. [Abstract] [Full-text]
  13. Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo.
    Arch Pharm Res, 31(4): 490-6. [Abstract] [Full-text]
  14. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212.
    Arch Pharm Res, 31(4): 468-73. [Abstract] [Full-text]
  15. Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt.
    Arch Pharm Res, 31(4): 438-44. [Abstract] [Full-text]
  16. Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E2 (COX-2) production of flavonoids from seeds of Prunus tomentosa Thunberg.
    Arch Pharm Res, 31(4): 424-8. [Abstract] [Full-text]
  17. Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe.
    Arch Pharm Res, 31(4): 415-8. [Abstract] [Full-text]
  18. Epigenetic Remodeling During Arsenical-Induced Malignant Transformation.
    Carcinogenesis. [Abstract] [Full-text]
  19. Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas.
    Pharmacotherapy, 28(5): 678-81. [Abstract] [Full-text]
  20. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    Pharmacotherapy, 28(5): 667-77. [Abstract] [Full-text]
  21. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances.
    Pharmacotherapy, 28(5): 656-66. [Abstract] [Full-text]
  22. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Pharmacotherapy, 28(5): 646-55. [Abstract] [Full-text]
  23. Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Pharmacotherapy, 28(5): 600-13. [Abstract] [Full-text]
  24. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Pharmacotherapy, 28(5): 591-9. [Abstract] [Full-text]
  25. Research publication by pharmacist authors in major medical journals: changes over a 10-year interval.
    Pharmacotherapy, 28(5): 584-90. [Abstract] [Full-text]
  26. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
    Pharmacotherapy, 28(5): 553-61. [Abstract] [Full-text]
  27. 203Pb-Labeled {alpha}-Melanocyte-Stimulating Hormone Peptide as an Imaging Probe for Melanoma Detection.
    J Nucl Med, 49(5): 823-829. [Abstract] [Full-text]
  28. Application of microscopy in authentication of traditional Tibetan medicinal plants of five Rhodiola (Crassulaceae) alpine species by comparative anatomy and micromorphology.
    Microsc Res Tech, 71(6): 448-58. [Abstract] [Full-text]
  29. Inhibition of D-amino-Acid oxidase activity induces pain relief in mice.
    Cell Mol Neurobiol, 28(4): 581-91. [Abstract] [Full-text]
  30. Antipsychotic Use in the Treatment of Outpatients With Schizophrenia in the VA From Fiscal Years 1999 to 2006.
    Psychiatr Serv, 59(5): 567-9. [Abstract] [Full-text]
  31. Use of antipsychotic drugs among dutch youths between 1997 and 2005.
    Psychiatr Serv, 59(5): 554-60. [Abstract] [Full-text]
  32. Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements.
    Psychiatr Serv, 59(5): 540-6. [Abstract] [Full-text]
  33. Impact of the CATIE Findings on State Mental Health Policy.
    Psychiatr Serv, 59(5): 534-6. [Abstract] [Full-text]
  34. Poly(D,L-lactide) nanoencapsulation to reduce photoinactivation of a sunscreen agent.
    Int J Cosmet Sci, 30(3): 219-27. [Abstract] [Full-text]
  35. Preparation and characterization of herbal creams for improvement of skin viscoelastic properties.
    Int J Cosmet Sci, 30(3): 183-93. [Abstract] [Full-text]
  36. Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab.
    J Clin Pharm Ther, 33(3): 321-5. [Abstract] [Full-text]
  37. Testing the validity of a translated pharmaceutical therapy-related quality of life instrument, using qualitative 'think aloud' methodology.
    J Clin Pharm Ther, 33(3): 279-87. [Abstract] [Full-text]
  38. Evaluation of the stability of morphine sulphate in combination with Instillagel.
    J Clin Pharm Ther, 33(3): 263-71. [Abstract] [Full-text]
  39. Patterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: a population-based study.
    J Clin Pharm Ther, 33(3): 243-9. [Abstract] [Full-text]
  40. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
    J Clin Pharm Ther, 33(3): 227-35. [Abstract] [Full-text]
  41. Lenalidomide in the treatment of multiple myeloma: a review.
    J Clin Pharm Ther, 33(3): 219-26. [Abstract] [Full-text]
  42. Soybean-based biomaterials: preparation, properties and tissue regeneration potential.
    Expert Rev Med Devices, 5(3): 349-58. [Abstract] [Full-text]
  43. Desirability-based multiobjective optimization for global QSAR studies: Application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles.
    J Comput Chem. [Abstract] [Full-text]
  44. Characterization of Polyion Complex Micelles Designed to Address the Challenges of Oligonucleotide Delivery.
    Pharm Res. [Abstract] [Full-text]
  45. ATF4-dependent transcription is a key mechanism in VEGF upregulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response.
    Blood. [Abstract] [Full-text]
  46. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
    Clin Cancer Res, 14(9): 2841-9. [Abstract] [Full-text]
  47. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.
    Cancer Res, 68(9): 3142-51. [Abstract] [Full-text]
  48. The lytic cassette of mycobacteriophage Ms6 encodes an enzyme with lipolytic activity.
    Microbiology, 154: 1364-71. [Abstract] [Full-text]
  49. Inhibition of Brain PGHS-2 Prevents the Preparturient Increase in Fetal ACTH Secretion in the Sheep Fetus.
    Endocrinology. [Abstract] [Full-text]
  50. The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.
    Endocrinology. [Abstract] [Full-text]
  51. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom.
    Pediatrics, 121(5): 1002-9. [Abstract] [Full-text]
  52. Co-oxidation-mediated xenobiotic activation and cytotoxicity by 12-lipoxygenase in intact platelets.
    Toxicology, 247(2): 154-60. [Abstract] [Full-text]
  53. Ab initio study of hydrogen-bond formation between aliphatic and phenolic hydroxy groups and selected amino acid side chains.
    J Phys Chem A, 112(18): 4342-54. [Abstract] [Full-text]
  54. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
    Oral Oncol, 44(5): 477-83. [Abstract] [Full-text]
  55. Case-finding algorithm for post-stroke depression in the veterans health administration.
    Int J Geriatr Psychiatry, 23(5): 517-22. [Abstract] [Full-text]
  56. Dispensed volumes of anti-asthmatic drugs related to the prevalence of asthma and COPD in Sweden.
    Pharmacoepidemiol Drug Saf, 17(5): 461-7. [Abstract] [Full-text]
  57. Lessons learned from a multidisciplinary heart failure clinic for older women: a randomised controlled trial.
    Age Ageing, 37(3): 282-7. [Abstract] [Full-text]
  58. Costs of interstitial cystitis in a managed care population.
    Urology, 71(5): 776-80; discussion 780-1. [Abstract] [Full-text]
  59. Consensus list of signals to detect potential adverse drug reactions in nursing homes.
    J Am Geriatr Soc, 56(5): 808-15. [Abstract] [Full-text]
  60. Excessive antibiotic use in men with prostatitis.
    Am J Med, 121(5): 444-9. [Abstract] [Full-text]
  61. The active site cysteinyls and hydrophobic cavity residues of ResA are important for cytochrome c maturation in Bacillus subtilis.
    J Bacteriol. [Abstract] [Full-text]
  62. Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis.
    Am J Med, 121(5): 419-25. [Abstract] [Full-text]
  63. Centella asiatica water extract inhibits iPLA(2) and cPLA(2) activities in rat cerebellum.
    Phytomedicine. [Abstract] [Full-text]
  64. Impact of Anesthesia on Valvular Function in Normal Rats During Echocardiography.
    Ultrasound Med Biol. [Abstract] [Full-text]
  65. Role of state policies in the adoption of naltrexone for substance abuse treatment.
    Health Serv Res, 43(3): 951-70. [Abstract] [Full-text]
  66. Absence of Transovarial Transmission of Borrelia duttonii, a Tick-Borne Relapsing Fever Agent, by the Vector Tick Ornithodoros moubata.
    Vector Borne Zoonotic Dis. [Abstract] [Full-text]
  67. Solid state stability of proteins III: Calorimetric (DSC) and spectroscopic (FTIR) characterization of thermal denaturation in freeze dried human growth hormone (hGH).
    J Pharm Sci. [Abstract] [Full-text]
  68. Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model.
    Pharm Res. [Abstract] [Full-text]
  69. High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.
    AIDS, 22(8): 931-5. [Abstract] [Full-text]
  70. Crystallization and preliminary X-ray crystallographic analysis of MacA from Actinobacillus actinomycetemcomitans.
    Acta Crystallogr Sect F Struct Biol Cryst Commun, 64: 391-3. [Abstract] [Full-text]
  71. Structure of monkey dimeric dihydrodiol dehydrogenase in complex with isoascorbic acid.
    Acta Crystallogr D Biol Crystallogr, 64: 532-42. [Abstract] [Full-text]
  72. Trypsin-immobilized fiber core in syringe needle for highly efficient proteolysis.
    Proteomics, 8(9): 1785-8. [Abstract] [Full-text]
  73. Protective effect of trihexyphenidyl on hydrogen peroxide-induced oxidative damage in PC12 cells.
    Neurosci Lett, 437(1): 50-4. [Abstract] [Full-text]
  74. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence.
    J Am Geriatr Soc, 56(5): 862-70. [Abstract] [Full-text]
  75. Pharmacokinetics of salvianolic acids after intravenous injection, with and without Panax quinquefolium protopanaxadiol saponins, in rats.
    J Ethnopharmacol, 117(3): 408-14. [Abstract] [Full-text]
  76. Investigations Concerning the Correlation of COX-1 Inhibitory and Hydroxyl Radical Scavenging Activity.
    Arch Pharm (Weinheim), 341(5): 281-7. [Abstract] [Full-text]
  77. Synthesis and Biological Activity of Functionalized Indole-2-carboxylates, Triazino- and Pyridazino-indoles.
    Arch Pharm (Weinheim), 341(5): 294-300. [Abstract] [Full-text]
  78. Safety and efficacy of a graduated intravenous insulin infusion protocol in critically ill trauma patients receiving specialized nutritional support.
    Nutrition, 24(6): 536-45. [Abstract] [Full-text]
  79. Design, synthesis and evaluation of 2-phenyl-1H-benzo[d]imidazole-4,7-diones as vascular smooth muscle cell proliferation inhibitors.
    Bioorg Med Chem Lett, 18(9): 2948-51. [Abstract] [Full-text]
  80. Nutrition disorder and immunologic parameters: study of the intestinal villi in growing rats.
    Nutrition, 24(6): 575-81. [Abstract] [Full-text]
  81. Polycation nanostructured lipid carrier, a novel nonviral vector constructed with triolein for efficient gene delivery.
    Biochem Biophys Res Commun, 370(3): 478-82. [Abstract] [Full-text]
  82. Fabrication, modification, and application of poly(methyl methacrylate) microfluidic chips.
    Electrophoresis, 29(9): 1801-14. [Abstract] [Full-text]
  83. Study of the process of secondary failure of sulphonylurea by a Markov model.
    Pharmacoepidemiol Drug Saf, 17(5): 511-6. [Abstract] [Full-text]
  84. Radionuclide calibrator measurements of (18)F in a 3ml plastic syringe.
    Appl Radiat Isot, 66(6): 988-93. [Abstract] [Full-text]
  85. Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria.
    J Ethnopharmacol, 117(3): 507-11. [Abstract] [Full-text]
  86. Transport of aspalathin, a Rooibos tea flavonoid, across the skin and intestinal epithelium.
    Phytother Res, 22(5): 699-704. [Abstract] [Full-text]
  87. Metabonomic and metallomic profiling in the amniotic fluid of malnourished pregnant rats.
    J Proteome Res, 7(5): 2151-7. [Abstract] [Full-text]
  88. Injection of neural progenitor cells improved learning and memory dysfunction after cerebral ischemia.
    Exp Neurol, 211(1): 194-202. [Abstract] [Full-text]
  89. Inhaled corticosteroids during pregnancy: A review of methodologic issues.
    Respir Med, 102(6): 862-75. [Abstract] [Full-text]
  90. Stereoselective disposition of S- and R-licarbazepine in mice.
    Chirality, 20(6): 796-804. [Abstract] [Full-text]
  91. Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model.
    Toxicol Appl Pharmacol, 229(1): 94-101. [Abstract] [Full-text]
  92. Synthesis and properties of pH and temperature sensitive P(NIPAAm-co-DMAEMA) hydrogels.
    Colloids Surf B Biointerfaces, 64(1): 34-41. [Abstract] [Full-text]
  93. Interdomain mobility and conformational stability of type III fibronectin domain pairs control surface adsorption, desorption and unfolding.
    Colloids Surf B Biointerfaces, 64(1): 1-9. [Abstract] [Full-text]
  94. Effect of formulation factors on incorporation of the hydrophilic peptide dalargin into PLGA and mPEG-PLGA nanoparticles.
    Biopolymers. [Abstract] [Full-text]
  95. Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.
    J Cell Physiol. [Abstract] [Full-text]
  96. Enhancement of Dissolution Rate of Gliclazide Using Solid Dispersions with Polyethylene Glycol 6000.
    AAPS PharmSciTech. [Abstract] [Full-text]
  97. Wax-incorporated Emulsion Gel Beads of Calcium Pectinate for Intragastric Floating Drug Delivery.
    AAPS PharmSciTech. [Abstract] [Full-text]
  98. Determination of Reference Ultrasound Parameters for Model and Hydrofluoroalkane Propellants Using High-Resolution Ultrasonic Spectroscopy.
    AAPS PharmSciTech. [Abstract] [Full-text]
  99. Comparative Study of Propranolol hydrochloride Release from Matrix Tablets with Kollidon(R)SR or Hydroxy Propyl Methyl Cellulose.
    AAPS PharmSciTech. [Abstract] [Full-text]
  100. Intestinal Absorption Mechanisms of Prenylated Flavonoids Present in the Heat-Processed Epimedium koreanum Nakai (Yin Yanghuo).
    Pharm Res. [Abstract] [Full-text]
  101. Automated conformational energy fitting for force-field development.
    J Mol Model. [Abstract] [Full-text]
  102. Synergism between particle-based multiplexing and microfluidics technologies may bring diagnostics closer to the patient.
    Anal Bioanal Chem. [Abstract] [Full-text]
  103. Calcium transport by mammary secretory cells: Mechanisms underlying transepithelial movement.
    Cell Mol Biol Lett. [Abstract] [Full-text]
  104. Potent In Vitro Antifungal Activity of Naturally Occurring Acetylenic Acids.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
  105. GTPase-mediated regulation of the Unfolded Protein Response in C. elegans is dependent on the AAA+ ATPase CDC-48.
    Mol Cell Biol. [Abstract] [Full-text]
  106. Intestinal and hepatobiliary transport of ximelagatran and its metabolites in pigs.
    Drug Metab Dispos. [Abstract] [Full-text]
  107. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation.
    J Mass Spectrom. [Abstract] [Full-text]
  108. Protective effect of caffeic acid phenethyl ester against carbon tetrachloride-induced hepatotoxicity in mice.
    Toxicology, 248(1): 18-24. [Abstract] [Full-text]
  109. Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by microarray analysis.
    Anticancer Drugs, 19(5): 503-515. [Abstract] [Full-text]
  110. Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine.
    Int J Pharm, 357(1): 55-60. [Abstract] [Full-text]
  111. Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents.
    J Control Release, 128(1): 50-9. [Abstract] [Full-text]
  112. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles.
    J Control Release, 128(1): 60-70. [Abstract] [Full-text]
  113. N-methyl-d-aspartate mechanisms in depolarization of augmenting expiratory neurons during the expulsive phase of fictive cough in decerebrate cats.
    Neuropharmacology, 54(7): 1120-7. [Abstract] [Full-text]
  114. Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)).
    Protein Expr Purif, 59(2): 249-57. [Abstract] [Full-text]
  115. Cloning, expression, purification, and characterization of a designer protein with repetitive sequences.
    Protein Expr Purif, 59(2): 203-14. [Abstract] [Full-text]
  116. Novel use of Eudragit((R)) NE 30D/Eudragit((R)) L 30D-55 blends as functional coating materials in time-delayed drug release applications.
    Int J Pharm, 357(1): 219-27. [Abstract] [Full-text]
  117. Process and formulation characterizations of the thermal adhesion granulation (TAG) process for improving granular properties.
    Int J Pharm, 357(1): 206-12. [Abstract] [Full-text]
  118. Controlling granule size by granulation liquid feed pulsing.
    Int J Pharm, 357(1): 132-8. [Abstract] [Full-text]
  119. Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation.
    Int J Pharm, 357(1): 295-304. [Abstract] [Full-text]
  120. The use of atomic force microscopy to study the conditioning of micronised budesonide.
    Int J Pharm, 357(1): 314-7. [Abstract] [Full-text]
  121. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
    Int J Pharm, 357(1): 189-98. [Abstract] [Full-text]
  122. Drug release responses of zinc ion crosslinked poly(methyl vinyl ether-co-maleic acid) matrix towards microwave.
    Int J Pharm, 357(1): 154-63. [Abstract] [Full-text]
  123. Controlled delivery of aspirin: Effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
    Int J Pharm, 357(1): 119-25. [Abstract] [Full-text]
  124. Effect of fluidisation activity on end-point detection of a fluid bed drying process.
    Int J Pharm, 357(1): 37-43. [Abstract] [Full-text]
  125. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
    Int J Pharm, 357(1): 126-31. [Abstract] [Full-text]
  126. Gamma scintigraphy for testing bioequivalence: A case study on two cromolyn sodium nasal spray preparations.
    Int J Pharm, 357(1): 70-6. [Abstract] [Full-text]
  127. Lyophilized Cheliensisin A submicron emulsion for intravenous injection: Characterization, in vitro and in vivo antitumor effect.
    Int J Pharm, 357(1): 139-47. [Abstract] [Full-text]
  128. Chemical method to enhance transungual transport and iontophoresis efficiency.
    Int J Pharm, 357(1): 61-9. [Abstract] [Full-text]
  129. Off-line and on-line measurements of drug-loaded hot-melt extruded films using Raman spectroscopy.
    Int J Pharm, 357(1): 77-84. [Abstract] [Full-text]
  130. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems.
    Int J Pharm, 357(1): 15-21. [Abstract] [Full-text]
  131. Interaction studies of DNA binding of ruthenium(II) mixed-ligand complexes: [Ru(phen)2(dtmi)]2+ and [Ru(phen)2(dtni)]2+.
    Spectrochim Acta A Mol Biomol Spectrosc, 70(1): 171-6. [Abstract] [Full-text]
  132. Highly sensitive and selective spectrophotometric and spectrofluorimetric methods for the determination of ropinirole hydrochloride in tablets.
    Spectrochim Acta A Mol Biomol Spectrosc, 70(1): 69-78. [Abstract] [Full-text]
  133. Kaempferol-7-O-beta-d-glucoside (KG) isolated from Smilax china L. rhizome induces G(2)/M phase arrest and apoptosis on HeLa cells in a p53-independent manner.
    Cancer Lett, 264(2): 229-40. [Abstract] [Full-text]
  134. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A(3) adenosine receptor agonist, in human lung cancer cells.
    Cancer Lett, 264(2): 309-15. [Abstract] [Full-text]
  135. Assessing the economic burden of breast cancer in a US managed care population.
    Breast Cancer Res Treat, 109(2): 367-77. [Abstract] [Full-text]
  136. Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center.
    Support Care Cancer. [Abstract] [Full-text]
  137. Antimalarial drug quality in the most severely malarious parts of Africa - a six country study.
    PLoS ONE, 3(5): e2132. [Abstract] [Full-text]
  138. Hyalocyte proliferation and ECM accumulation modulated by bFGF and TGF-beta1.
    Graefes Arch Clin Exp Ophthalmol. [Abstract] [Full-text]
  139. Oxidized phospholipids: emerging lipid mediators in pathophysiology.
    Curr Opin Lipidol, 19(3): 289-94. [Abstract] [Full-text]
  140. Amiodarone-induced pulmonary toxicity.
    Br J Clin Pharmacol. [Abstract] [Full-text]
  141. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women.
    Br J Clin Pharmacol. [Abstract] [Full-text]
  142. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males.
    Br J Clin Pharmacol. [Abstract] [Full-text]
  143. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate.
    J Agric Food Chem, 56(9): 3350-6. [Abstract] [Full-text]
  144. Cytotoxic phenylpropanoids from carrot.
    J Agric Food Chem, 56(9): 3024-7. [Abstract] [Full-text]
  145. Changes in volatile compounds and overall aroma profile during storage of coffee brews at 4 and 25 degrees C.
    J Agric Food Chem, 56(9): 3145-54. [Abstract] [Full-text]
  146. Psychotic mania associated with mefloquine in a bipolar patient.
    South Med J, 101(5): 550-1. [Abstract] [Full-text]
  147. Development of Tolerance to the Dietary Plant Secondary Metabolite 1,8-cineole by the Brushtail Possum (Trichosurus vulpecula).
    J Chem Ecol, 34(5): 672-80. [Abstract] [Full-text]
  148. Antimicrobial, dehydroascorbate reductase, and monodehydroascorbate reductase activities of defensin from sweet potato [Ipomoea batatas (L.) Lam. 'Tainong 57'] storage roots.
    J Agric Food Chem, 56(9): 2989-95. [Abstract] [Full-text]
  149. Effects of the mango components mangiferin and quercetin and the putative mangiferin metabolite norathyriol on the transactivation of peroxisome proliferator-activated receptor isoforms.
    J Agric Food Chem, 56(9): 3037-42. [Abstract] [Full-text]
  150. Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis.
    J Clin Microbiol, 46(5): 1631-40. [Abstract] [Full-text]
  151. The relationship of potential G-quadruplex sequences in cis-upstream regions of the human genome to SP1-binding elements.
    Nucleic Acids Res, 36(8): 2700-4. [Abstract] [Full-text]
  152. Characterization of the Molecular Interaction between Tropoelastin and DANCE/Fibulin-5.
    J Biochem, 143(5): 633-639. [Abstract] [Full-text]
  153. Improving investigational drug service operations through development of an innovative computer system.
    Am J Health Syst Pharm, 65(10): 969-73. [Abstract] [Full-text]
  154. Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia.
    Fertil Steril. [Abstract] [Full-text]
  155. Use of a mandatory declination form in a program for influenza vaccination of healthcare workers.
    Infect Control Hosp Epidemiol, 29(4): 302-8. [Abstract] [Full-text]
  156. A population pharmacokinetic turnover and surge-function model for describing melatonin biological rhythm in healthy male subjects.
    J Pharm Sci. [Abstract] [Full-text]
  157. Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level.
    J Asian Nat Prod Res, 10(5): 473-9. [Abstract] [Full-text]
  158. Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.
    Psychopharmacology (Berl). [Abstract] [Full-text]
  159. Insulin temperature and stability under simulated transit conditions.
    Am J Health Syst Pharm, 65(10): 953-63. [Abstract] [Full-text]
  160. Characteristics of the amiodarone-warfarin interaction during long-term follow-up.
    Am J Health Syst Pharm, 65(10): 947-52. [Abstract] [Full-text]
  161. Acute renal failure, gastrointestinal bleeding, and cardiac arrhythmia after administration of arsenic trioxide for acute promyelocytic leukemia.
    Am J Health Syst Pharm, 65(10): 941-6. [Abstract] [Full-text]
  162. Diagnosis and treatment of insomnia.
    Am J Health Syst Pharm, 65(10): 927-34. [Abstract] [Full-text]
  163. The Impact of mecA Gene Testing and Infectious Diseases Pharmacists' Intervention on the Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a University Hospital.
    J Clin Microbiol. [Abstract] [Full-text]
  164. Development of Cell Lines that Provide Tightly Controlled Temporal Translation of the Human Cytomegalovirus IE2 Proteins for Complementation and Functional Analyses of Growth-Impaired and Non-Viable IE2 Mutant Viruses.
    J Virol. [Abstract] [Full-text]
  165. Comparison of enteral and intravenous lansoprazole pharmacodynamic response in critically ill patients.
    Aliment Pharmacol Ther. [Abstract] [Full-text]
  166. Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.
    J Neuropathol Exp Neurol, 67(5): 456-69. [Abstract] [Full-text]
  167. Analysis of the peptide profile of milk and its changes during thermal treatment and storage.
    J Agric Food Chem, 56(9): 2899-906. [Abstract] [Full-text]
  168. Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?
    J Clin Endocrinol Metab, 93(5): 2009-12. [Abstract] [Full-text]
  169. Bile acid levels are increased in the liver of patients with steatohepatitis.
    Eur J Gastroenterol Hepatol, 20(6): 519-25. [Abstract] [Full-text]
  170. A Pathogenic Fungi Diphenyl Ether Phytotoxin Targets Plant Enoyl (Acyl Carrier Protein) Reductase.
    Plant Physiol. [Abstract] [Full-text]
  171. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.
    J Antimicrob Chemother. [Abstract] [Full-text]
  172. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.
    J Cyst Fibros. [Abstract] [Full-text]
  173. Cost-effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer.
    Pharmacogenomics, 9(5): 539-49. [Abstract] [Full-text]
  174. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
    Eur J Contracept Reprod Health Care, 13(2): 123-32. [Abstract] [Full-text]
  175. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    J Microencapsul. [Abstract] [Full-text]
  176. Interplay Between Intestinal pH, Transit Time and Feed Status on the In Vivo Performance of pH Responsive Ileo-Colonic Release Systems.
    Pharm Res. [Abstract] [Full-text]
  177. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
    Cancer Chemother Pharmacol. [Abstract] [Full-text]
  178. Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese.
    Food Chem Toxicol, 46(6): 2261-6. [Abstract] [Full-text]
  179. Base-catalyzed intramolecular hydroamination of conjugated enynes.
    Org Lett, 10(10): 2023-6. [Abstract] [Full-text]
  180. Development and validation of a microemulsion electrokinetic chromatography method for patulin quantification in commercial apple juice.
    Food Chem Toxicol, 46(6): 2251-7. [Abstract] [Full-text]
  181. Corn oil enhancing hepatic lipid peroxidation induced by CCl4 does not aggravate liver fibrosis in rats.
    Food Chem Toxicol, 46(6): 2267-73. [Abstract] [Full-text]
  182. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons.
    Vaccine, 26(21): 2596-600. [Abstract] [Full-text]
  183. Phorbasides A-E, cytotoxic chlorocyclopropane macrolide glycosides from the marine sponge Phorbas sp. CD determination of C-methyl sugar configurations.
    J Org Chem, 73(10): 3699-706. [Abstract] [Full-text]
  184. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling.
    J Neurochem. [Abstract] [Full-text]
  185. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: An observational study.
    Aust Crit Care, 21(2): 110-6. [Abstract] [Full-text]
  186. Synthesis and structure-antibacterial activity of triazolyl oxazolidinones containing long chain acyl moiety.
    Eur J Med Chem, 43(5): 1095-104. [Abstract] [Full-text]
  187. A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor.
    J Mol Graph Model, 26(8): 1276-86. [Abstract] [Full-text]
  188. Molecular docking/dynamics studies of Aurora A kinase inhibitors.
    J Mol Graph Model, 26(8): 1213-22. [Abstract] [Full-text]
  189. Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides.
    Eur J Med Chem, 43(5): 1105-13. [Abstract] [Full-text]
  190. 4-Thiazolidinone - A biologically active scaffold.
    Eur J Med Chem, 43(5): 897-905. [Abstract] [Full-text]
  191. Basic 3-hydroxypyridin-4-ones: Potential antimalarial agents.
    Eur J Med Chem, 43(5): 1035-47. [Abstract] [Full-text]
  192. N-{[(6-Substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: Synthesis and pharmacological evaluation.
    Eur J Med Chem, 43(5): 1114-22. [Abstract] [Full-text]
  193. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
    Eur J Med Chem, 43(5): 981-5. [Abstract] [Full-text]
  194. Synthesis, characterization and biological activity of Pt(II) and Pt(IV) complexes with 5-methyl-5(4-pyridyl)-2,4-imidazolidenedione.
    Eur J Med Chem, 43(5): 958-65. [Abstract] [Full-text]
  195. QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.
    Eur J Med Chem, 43(5): 1071-80. [Abstract] [Full-text]
  196. An examination of productivity and resource utilization associated with epoetin alfa treatment in employees with predialysis chronic kidney disease.
    J Occup Environ Med, 50(5): 584-9. [Abstract] [Full-text]
  197. The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization.
    J Occup Environ Med, 50(5): 535-41. [Abstract] [Full-text]
  198. Testing electronic algorithms to create disease registries in a safety net system.
    J Health Care Poor Underserved, 19(2): 452-65. [Abstract] [Full-text]
  199. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: A multi-method study.
    Health Policy. [Abstract] [Full-text]
  200. Low adiponectin levels in primary hypertriglyceridemic male patients.
    Nutr Metab Cardiovasc Dis. [Abstract] [Full-text]
  201. Multitargeted therapy of cancer by silymarin.
    Cancer Lett. [Abstract] [Full-text]
  202. SF2/ASF TORCs up translation.
    Mol Cell, 30(3): 262-3. [Abstract] [Full-text]
  203. Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells.
    Cancer Lett. [Abstract] [Full-text]
  204. Rural pharmacy in New Zealand: effects of a compulsory externship on student perspectives and implications for workforce shortage.
    Aust J Rural Health, 16(3): 150-5. [Abstract] [Full-text]
  205. Ixabepilone: a new microtubule-targeting agent for breast cancer.
    Expert Rev Anticancer Ther, 8(5): 671-81. [Abstract] [Full-text]
  206. Additive empirical force field for hexopyranose monosaccharides.
    J Comput Chem. [Abstract] [Full-text]
  207. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
    J Gene Med. [Abstract] [Full-text]
  208. Structure elucidation and complete NMR spectral assignments of four new diterpenoids from Smallantus sonchifolius.
    Magn Reson Chem. [Abstract] [Full-text]
  209. Three new flavanols from Daphne giraldii.
    J Asian Nat Prod Res, 10(6): 547-50. [Abstract] [Full-text]
  210. Structural and functional alterations in the rat lung following whole thoracic irradiation with moderate doses: Injury and recovery.
    Int J Radiat Biol, 84(6): 487-97. [Abstract] [Full-text]
  211. Formation of large vacuoles induced by cooperative effects of oncostatin M and dexamethasone in human fetal liver cells.
    Med Mol Morphol, 41(1): 53-8. [Abstract] [Full-text]
  212. Assessing antibiotic therapy for Acinetobacter baumannii infections in an academic medical center.
    Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
  213. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Behav Pharmacol, 19(3): 265-9. [Abstract] [Full-text]
  214. Behavioral characterization of serotonergic activation in the flatworm Planaria.
    Behav Pharmacol, 19(3): 177-82. [Abstract] [Full-text]
  215. 'I'm fine doing it on my own': partnerships between young people and their parents in the management of medication for asthma and diabetes.
    J Child Health Care, 12(2): 116-28. [Abstract] [Full-text]
  216. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile.
    J Antimicrob Chemother. [Abstract] [Full-text]
  217. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group.
    J Clin Epidemiol. [Abstract] [Full-text]
  218. The Australian funding debate on quadrivalent HPV vaccine: A case study for the national pharmaceutical policy.
    Health Policy. [Abstract] [Full-text]
  219. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice.
    Am J Obstet Gynecol. [Abstract] [Full-text]
  220. Differential signaling of sphingosine derivatives in U937 human monocytes depends on the degree of N-methylation.
    Prostaglandins Other Lipid Mediat, 86(1): 68-72. [Abstract] [Full-text]
  221. Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis.
    Biochem Pharmacol, 75(11): 2135-46. [Abstract] [Full-text]
  222. Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity.
    Life Sci, 82(21): 1045-9. [Abstract] [Full-text]
  223. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Bioorg Med Chem, 16(9): 4829-38. [Abstract] [Full-text]
  224. Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography.
    J Pharm Biomed Anal, 47(2): 429-34. [Abstract] [Full-text]
  225. Synthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer.
    J Comb Chem, 10(3): 475-83. [Abstract] [Full-text]
  226. Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.
    Bioorg Med Chem, 16(9): 4759-800. [Abstract] [Full-text]
  227. Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers.
    J Colloid Interface Sci, 322(1): 263-73. [Abstract] [Full-text]
  228. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
    Bioorg Med Chem, 16(9): 5254-65. [Abstract] [Full-text]
  229. Reaction of 2'-deoxycytidine with peroxynitrite in the presence of ammonium bromide.
    Bioorg Med Chem, 16(9): 5164-70. [Abstract] [Full-text]
  230. Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor.
    Bioorg Med Chem, 16(9): 5216-31. [Abstract] [Full-text]
  231. GC-MS studies on acylated derivatives of 3-methoxy-4-methyl- and 4-methoxy-3-methyl-phenethylamines: regioisomers related to 3,4-MDMA.
    Forensic Sci Int, 178(1): 61-82. [Abstract] [Full-text]
  232. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
    Bioorg Med Chem, 16(9): 5207-15. [Abstract] [Full-text]
  233. p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis.
    J Biol Chem, 283(20): 14132-14143. [Abstract] [Full-text]
  234. Aggregation and surface properties of F-specific RNA phages: implication for membrane filtration processes.
    Water Res, 42(10): 2769-77. [Abstract] [Full-text]
  235. Characterization of N,N,-dimethyl-d-erythro-sphingosine-induced apoptosis and signaling in U937 cells: Independence of sphingosine kinase inhibition.
    Prostaglandins Other Lipid Mediat, 86(1): 18-25. [Abstract] [Full-text]
  236. Isolation and identification of thiohomosildenafil and thiosildenafil in health supplements.
    J Pharm Biomed Anal, 47(2): 279-84. [Abstract] [Full-text]
  237. Simultaneous determination of 10 active components in traditional Chinese medicine "YIGONG" capsule by RP-HPLC-DAD.
    J Pharm Biomed Anal, 47(2): 442-7. [Abstract] [Full-text]
  238. Prediction of calibration curves in ria of digoxin Influence of some variables.
    J Pharm Biomed Anal, 47(2): 435-41. [Abstract] [Full-text]
  239. The selenium levels of mothers and their neonates using hair, breast milk, meconium, and maternal and umbilical cord blood in Van Basin.
    Biol Trace Elem Res, 122(3): 206-15. [Abstract] [Full-text]
  240. HPLC assay with UV detection for determination of RBC purine nucleotide concentrations and application for biomarker study in vivo.
    J Pharm Biomed Anal, 47(2): 377-82. [Abstract] [Full-text]
  241. Validation of an HPLC-MS method for rociverine tablet dissolution analysis.
    J Pharm Biomed Anal, 47(2): 422-8. [Abstract] [Full-text]
  242. The use of net analyte signal orthogonalization in the separation of multi-component diffraction patterns obtained from X-ray powder diffraction of intact compacts.
    J Pharm Biomed Anal, 47(2): 238-47. [Abstract] [Full-text]
  243. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    J Pharm Biomed Anal, 47(2): 360-70. [Abstract] [Full-text]
  244. Aqueous chromatographic system for separation of biomolecules using thermoresponsive polymer modified stationary phase.
    J Chromatogr A, 1191(1): 157-61. [Abstract] [Full-text]
  245. Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement.
    J Pharm Biomed Anal, 47(2): 255-9. [Abstract] [Full-text]
  246. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
    Macromol Biosci, 8(5): 441-50. [Abstract] [Full-text]
  247. Novel nanomaterials for clinical neuroscience.
    J Neuroimmune Pharmacol, 3(2): 83-94. [Abstract] [Full-text]
  248. Assessment of heavy metals concentrations in soil samples from the vicinity of busy roads: influence on Drosophila melanogaster life cycle.
    Biol Trace Elem Res, 122(3): 292-9. [Abstract] [Full-text]
  249. Preparation of novel beta-cyclodextrin chiral stationary phase based on click chemistry.
    J Chromatogr A, 1191(1): 188-92. [Abstract] [Full-text]
  250. Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells.
    J Biomed Mater Res A, 85(4): 983-92. [Abstract] [Full-text]
  251. Costs of severely ill members and specialty medication use in a commercially insured population.
    Health Aff (Millwood), 27(3): 824-34. [Abstract] [Full-text]
  252. Tobacco Use and Cessation Counseling: Cross-CountryData from the Global Health Professions Student Survey (GHPSS), 2005-2007.
    Tob Control. [Abstract] [Full-text]
  253. Prescription Tracking and Public Health.
    J Gen Intern Med. [Abstract] [Full-text]
  254. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    J Hypertens, 26(6): 1110-8. [Abstract] [Full-text]
  255. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome.
    Ann Fam Med, 6(3): 253-62. [Abstract] [Full-text]
  256. Treated prevalence and incidence of dementia among national health insurance enrollees in taiwan, 1996-2003.
    J Geriatr Psychiatry Neurol, 21(2): 142-8. [Abstract] [Full-text]
  257. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier.
    FASEB J. [Abstract] [Full-text]
  258. Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic.
    Diabetes Technol Ther, 10(3): 220-6. [Abstract] [Full-text]
  259. Enhanced Immunogenicity of Peptide P277 by Heat Shock Protein HSP65 Vector Carrying Tandem Repeats of P277 to Prevent Type 1 Diabetes in NOD Mice.
    Exp Clin Endocrinol Diabetes. [Abstract] [Full-text]
  260. Swelling and aspirin release study: cross-linked pH-sensitive vinyl acetate-co-acrylic acid (VAC-co-AA) hydrogels.
    Drug Dev Ind Pharm, 34(5): 512-21. [Abstract] [Full-text]
  261. Complexation of furosemide with fulvic acid extracted from shilajit: a novel approach.
    Drug Dev Ind Pharm, 34(5): 506-11. [Abstract] [Full-text]
  262. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A.
    Drug Dev Ind Pharm, 34(5): 492-8. [Abstract] [Full-text]
  263. Pharmacokinetic investigation on a novel antitumour platinum compound in rabbit plasma by inductively coupled plasma mass spectrometry after intravenous administration.
    Drug Dev Ind Pharm, 34(5): 472-7. [Abstract] [Full-text]
  264. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers.
    Drug Dev Ind Pharm, 34(5): 465-71. [Abstract] [Full-text]
  265. PEITC Induces G1 Cell Cycle Arrest on HT-29 Cells Through the Activation of p38 MAPK Signaling Pathway.
    AAPS J. [Abstract] [Full-text]
  266. Hepatic cytochrome P450 activity and pollutant concentrations in paradise shelducks and southern black-backed gulls in the South Island of New Zealand.
    Ecotoxicology. [Abstract] [Full-text]
  267. Tetrakis(trifluoromethanesulfonyl)propane: highly effective Brønsted acid catalyst for vinylogous Mukaiyama-Michael reaction of alpha,beta-enones with silyloxyfurans.
    Chem Commun (Camb). [Abstract] [Full-text]
  268. Loading effects of silver oxides upon generation of reactive oxygen species in semiconductor photocatalysis.
    Phys Chem Chem Phys, 10(20): 2986-92. [Abstract] [Full-text]
  269. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat.
    Toxicol Lett, 178(3): 176-80. [Abstract] [Full-text]
  270. Adsorption of insulin onto infusion sets used in adult intensive care unit and neonatal care settings.
    Diabetes Res Clin Pract, 80(3): e11-3. [Abstract] [Full-text]
  271. Apoptosis in transgenic mice expressing the P301L mutated form of human tau.
    Mol Med, 14(5): 309-17. [Abstract] [Full-text]
  272. Predictors of mortality in hospitalized diabetic patients: A 7-year prospective study.
    Diabetes Res Clin Pract, 80(3): 449-54. [Abstract] [Full-text]
  273. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors.
    Breast Cancer Res Treat, 109(3): 573-9. [Abstract] [Full-text]
  274. Detection and prevention of medication misadventures in general practice.
    Int J Qual Health Care, 20(3): 192-9. [Abstract] [Full-text]
  275. Conformity of commercial oral single solid unit dose packages in hospital pharmacy practice.
    Int J Qual Health Care, 20(3): 206-10. [Abstract] [Full-text]
  276. Monitoring of volatile organic compounds in non-residential indoor environments.
    Indoor Air, 18(3): 250-6. [Abstract] [Full-text]
  277. Structure elucidation and complete NMR spectral assignments of two new dammarane-type tetraglycosides from Panax quinquefolium.
    Magn Reson Chem. [Abstract] [Full-text]
  278. QSAR model for alignment-free prediction of human breast cancer biomarkers based on electrostatic potentials of protein pseudofolding HP-lattice networks.
    J Comput Chem. [Abstract] [Full-text]
  279. Telithromycin Pharmacokinetics in Rat Model of Diabetes Mellitus Induced by Alloxan or Streptozotocin.
    Pharm Res. [Abstract] [Full-text]
  280. Inflammation in Chronic Heart Failure (June).
    Ann Pharmacother. [Abstract] [Full-text]
  281. A survey of inhalational anaesthetic abuse in anaesthesia training programmes.
    Anaesthesia, 63(6): 616-20. [Abstract] [Full-text]
  282. Mitochondrial dysfunction and cellular stress progression after ultraviolet B irradiation in human keratinocytes.
    Photodermatol Photoimmunol Photomed, 24(3): 115-22. [Abstract] [Full-text]
  283. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Cytopathology. [Abstract] [Full-text]
  284. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
    Scand J Immunol, 67(6): 626-31. [Abstract] [Full-text]
  285. A newer immunoglobulin intravenous (IGIV) - Gammagard liquid 10%: evaluation of efficacy, safety, tolerability and impact on patient care.
    Expert Opin Biol Ther, 8(6): 799-804. [Abstract] [Full-text]
  286. Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.
    Pigment Cell Melanoma Res, 21(3): 368-78. [Abstract] [Full-text]
  287. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.
    Br J Clin Pharmacol, 65(6): 917-26. [Abstract] [Full-text]
  288. Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care.
    Ir J Med Sci, 177(2): 93-7. [Abstract] [Full-text]
  289. Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.
    Br J Clin Pharmacol, 65(6): 893-907. [Abstract] [Full-text]
  290. Synaptic alpha 5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex.
    Cereb Cortex, 18(6): 1260-71. [Abstract] [Full-text]
  291. Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity.
    Breast Cancer Res Treat, 109(3): 443-50. [Abstract] [Full-text]
  292. Effects of a Consumer Driven Health Plan on Pharmaceutical Spending and Utilization.
    Health Serv Res. [Abstract] [Full-text]
  293. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells.
    Mol Nutr Food Res. [Abstract] [Full-text]
  294. Characterization of moisture-protective polymer coatings using differential scanning calorimetry and dynamic vapor sorption.
    J Pharm Sci. [Abstract] [Full-text]
  295. Quality by design, part III: Study of curing process of sustained release coated products using NIR spectroscopy.
    J Pharm Sci. [Abstract] [Full-text]